重编程巨核细胞以控制释放携带单链血红素A2受体-G蛋白复合体的血小板状颗粒具有治疗潜力的治疗潜力

Renzhong Lu1, Yan Li1, Anna Xu1

  • 1The Center for Experimental Therapeutics and Pharmacoinformatics, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.

Cells
|December 22, 2023
PubMed
概括

研究人员设计了单链融合蛋白来控制血小板聚合. 这些蛋白质通过血小板结合颗粒传递,可以通过与血栓素A2相互作用来促进或抑制聚合,从而提供治疗潜力.